These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24526593)

  • 1. GAGs and GAGs diseases: when pathophysiology supports the clinic.
    Costantini E; Lazzeri M; Porena M
    Urologia; 2013; 80(3):173-8. PubMed ID: 24526593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis.
    Parsons CL
    Urology; 2007 Apr; 69(4 Suppl):9-16. PubMed ID: 17462486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical glycosaminoglycans in the management of chronic cystitis.
    Iacovelli V; Topazio L; Gaziev G; Bove P; Vespasiani G; Finazzi Agrò E
    Minerva Urol Nefrol; 2013 Dec; 65(4):249-62. PubMed ID: 24091478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symposium report on urothelial dysfunction: pathophysiology and novel therapies.
    Kanai A; de Groat W; Birder L; Chai T; Hultgren S; Fowler C; Fry C
    J Urol; 2006 May; 175(5):1624-9. PubMed ID: 16600715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for the function of glycosaminoglycans in the urinary tract.
    Parsons CL
    World J Urol; 1994; 12(1):38-42. PubMed ID: 8012414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract.
    Hurst RE
    World J Urol; 1994; 12(1):3-10. PubMed ID: 8012413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis.
    Kuo HC
    Int J Urol; 2014 Apr; 21 Suppl 1():34-41. PubMed ID: 24807491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycans: how much do we know about their role in the bladder?
    Klingler CH
    Urologia; 2016 Jun; 83 Suppl 1():11-4. PubMed ID: 27405344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ls clinical practice aligned with the latest scientific evidence on GAG therapy?
    Janssen DAW
    Urologia; 2017 Sep; 84(Suppl 1):16-20. PubMed ID: 28862729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physiological function of the urothelium--more than a simple barrier.
    Lazzeri M
    Urol Int; 2006; 76(4):289-95. PubMed ID: 16679827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis.
    Wei DC; Politano VA; Selzer MG; Lokeshwar VB
    J Urol; 2000 May; 163(5):1577-83. PubMed ID: 10751891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of Urothelial Inflammation, Apoptosis, and Junction Protein in Patients with Various Bladder Conditions and Storage Bladder Symptoms Suggest Common Pathway Involved in Underlying Pathophysiology.
    Liu HT; Jiang YH; Kuo HC
    Low Urin Tract Symptoms; 2015 May; 7(2):102-7. PubMed ID: 26663690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosaminoglycans excretion in interstitial cystitis.
    Akçay T; Konukoğlu D
    Int Urol Nephrol; 1999; 31(4):431-5. PubMed ID: 10668936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency.
    Ke QS; Jhang JF; Lin TY; Ho HC; Jiang YH; Hsu YH; Kuo HC
    Tzu Chi Med J; 2019; 31(3):135-143. PubMed ID: 31258287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology and pathophysiology of painful bladder diseases.
    Holm-Bentzen M
    Urol Int; 1989; 44(6):327-31. PubMed ID: 2623783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the bladder surface in interstitial cystitis/painful bladder syndrome.
    Teichman JM; Moldwin R
    Can J Urol; 2007 Aug; 14(4):3599-607. PubMed ID: 17784979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease.
    Damiano R; Cicione A
    Ther Adv Urol; 2011 Oct; 3(5):223-32. PubMed ID: 22046200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence.
    Lazzeri M; Hurle R; Casale P; Buffi N; Lughezzani G; Fiorini G; Peschechera R; Pasini L; Zandegiacomo S; Benetti A; Taverna G; Guazzoni G; Barbagli G
    Ther Adv Urol; 2016 Apr; 8(2):91-9. PubMed ID: 27034722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis.
    Hurst RE; Moldwin RM; Mulholland SG
    Urology; 2007 Apr; 69(4 Suppl):17-23. PubMed ID: 17462475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of the nature of bladder mucosal glycoconjugates and their role in interstitial cystitis.
    Bhavanandan VP; Erickson DR
    Indian J Biochem Biophys; 1997; 34(1-2):205-11. PubMed ID: 9343952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.